| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $251K | — | -2.6% |
| R&D Expense | $4.1M | — | -21.4% |
| SG&A Expense | $3.8M | — | +39.4% |
| Operating Income | -$7.6M | — | +0.5% |
| Pre-tax Income | -$7.2M | — | +1.4% |
| Net Income | -$7.2M | — | +1.4% |
| EPS (Basic) | -$0.32 | — | +27.3% |
| EPS (Diluted) | -$0.32 | — | +27.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $50.7M | +8.3% | +42.8% |
| Current Assets | $53.3M | +6.7% | +38.8% |
| Total Assets | $53.3M | +6.6% | +38.7% |
| Current Liabilities | $3.5M | -39.6% | -18.3% |
| Total Liabilities | $4.3M | -37.9% | -14.6% |
| Stockholders' Equity | $49.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.2M | — | -119.5% |
| Investing Cash Flow | -$885K | — | — |
| Financing Cash Flow | $11.0M | — | — |
| +46.8% |